{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"page_content": "using deepTools3.\n\n5-mC DNA dot blot\n\n128\n\nGenomic DNA was extracted from P21 retinae (Wizard SV genomic DNA purification\n\nKit). Purified DNA was quantified, sonicated, denatured, and transferred to the Nylon\n\nmembrane (RPN303B, GE Healthcare) according to the Cell Signaling DNA Dot Blot\n\nProtocol. 5methylcytosine (5-mC) Ab (#28692, Cell Signaling) was used to detect global\n\nDNA methylation of the samples. Methylene blue staining was used to verify equal DNA\n\nloading across samples.\n\n129\n\n1.\n\n2.\n\n3.\n\n4.\n\n5.\n\n6.\n\n7.\n\n8.\n\n9.\n\n5.7 References\n\nFerreira, R., Naguibneva, I., Pritchard, L. L., Ait-Si-Ali, S. & Harel-Bellan, A. The\n\nRb/chromatin connection and epigenetic control: opinion. Oncogene 20, 3128\u20133133\n\n(2001).\n\nDonovan, S. L. & Dyer, M. A. Developmental defects in Rb-deficient retinae. Vis. Res 44,\n\n3323\u20133333 (2004).\n\nChen, D. et al. Cell-specific effects of RB or RB/p107 loss on retinal development implicate\n\nan intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539\u2013551\n\n(2004).\n\nFriend, S. H. et al. A human DNA segment with properties of the gene that predisposes to\n\nretinoblastoma and osteosarcoma. Nature 323, 643\u2013646 (1986).\n\nRushlow, D. E. et al. Characterisation of retinoblastomas without RB1 mutations: genomic,\n\ngene expression, and clinical studies. LANCET Oncol. 14, 327\u2013334 (2013).\n\nZhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses.\n\nNature 481, 329\u2013334 (2012).\n\nSC Wu, C. B. Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-\n\nE2F pathway and is nonessential for osteosarcoma tumorigenesis. Oncotarget 9, 32580\u2013\n\n32592 (2018).\n\nNiu, J. et al. Transcriptional activation of the senescence regulator Lsh by E2F1. Mech.\n\nAgeing Dev. 132, 180\u2013186 (2011).\n\nXiao, D. et al. Chromatin remodeling factor LSH is upregulated by the LRP6-GSK3beta-E2F1\n\naxis linking reversely with survival in gliomas. Theranostics 7, 132\u2013143 (2017).\n\n130", "metadata": {"source": "./documents/UC Irvine/JW_Dissertation_20220824.pdf"}, "type": "Document"}}